Orientbio Inc. (002630.XKRX) Financials
All currency values in ₩ millions unless otherwise noted
Scroll
| Income Statement | MAR 2026 | MAR 2025 | MAR 2024 | MAR 2023 | MAR 2022 |
|---|---|---|---|---|---|
| Revenues | |||||
| Revenue | ₩29,754 | ₩29,398 | ₩28,005 | ₩28,819 | ₩26,276 |
| Cost of Revenue | ₩24,570 | ₩22,201 | ₩18,421 | ₩18,995 | ₩17,263 |
| Gross Profit | ₩5,184 | ₩7,197 | ₩9,584 | ₩9,824 | ₩9,014 |
| Total Operating Expenses | ₩9,316 | ₩10,273 | ₩5,130 | ₩6,359 | ₩12,794 |
| Operating Income | -₩4,132 | -₩3,076 | ₩4,455 | ₩3,465 | -₩3,781 |
| Non-Operating | |||||
| Net Interest Expense | -₩128 | -₩220 | -₩57 | -₩252 | -₩433 |
| Income Tax Expense | — | — | — | -₩167 | ₩69 |
| Net Income | |||||
| Net Income | -₩4,567 | -₩13,195 | ₩12,871 | -₩12,424 | ₩34,198 |
| Per Share Data | |||||
| Revenue Per Share | ₩501.90 | ₩495.88 | ₩237.16 | ₩243.57 | ₩221.29 |
| EPS (Basic) | -₩77.03 | -₩222.00 | ₩109.00 | -₩105.00 | ₩288.00 |
| EPS (Diluted) | -₩77.03 | -₩222.00 | ₩109.00 | -₩105.00 | ₩288.00 |
| Shares Outstanding | 59.3M | 59.3M | 118.1M | 118.3M | 118.7M |
Orientbio (002630.XKRX) financials: revenue, profit and margins
Orientbio (002630.XKRX) generated about KRW 29.8 billion in revenue and -KRW 4.6 billion in net income (a -15.3% net margin) over the trailing twelve months, growing at roughly 3.2% a year. Figures are from company filings; this is analysis, not investment advice.
Frequently asked
What is Orientbio's (002630.XKRX) revenue?+
Orientbio generated about KRW 29.8 billion in revenue over the trailing twelve months. Revenue has grown at roughly 3.2% a year over the past five years. Revenue is the top line, before any costs; what matters for value is how much of it survives to free cash flow. The full income statement, balance sheet and cash-flow statement are on this tab.
Is Orientbio profitable?+
Orientbio reported about -KRW 4.6 billion in net loss over the trailing twelve months, a net margin of roughly -15.3%. Net income is the bottom line after all costs, interest and taxes. Compare it to free cash flow on this tab, since reported profit and actual cash generated can diverge.
What are Orientbio's profit margins?+
Orientbio runs a gross margin of about 17.4%, an operating margin of about -13.9%, a net margin of about -15.3%. Margins show how much of each sales dollar a company keeps at each stage. Stable or rising margins usually signal pricing power and cost discipline; falling margins are worth investigating. See the multi-year trend on this tab.
How fast is Orientbio growing?+
Orientbio's revenue has compounded at roughly 3.2% a year over the past five years. Growth only creates value when it is profitable and cash-generative, so read this rate alongside 002630.XKRX's margins and free cash flow. This is analysis from company filings, not investment advice.
Related stocks: Biotechnology
Spot a number that looks wrong?
Data sourced from company filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.